| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 10/07/2009 | CN101549083A Chinese materia medica foot bath preserving health essence |
| 10/07/2009 | CN101549071A Traditional Chinese medicine combination for treating lumbar intervertebral disc protrusion lumbago |
| 10/07/2009 | CN101549058A Cold-dispelling pus-drawing-out stasis-resolving plaster |
| 10/07/2009 | CN101549031A Chinese medical liniment for curing neck and lumbar pain |
| 10/07/2009 | CN101549028A Son-mother hot compressing fumigation chamber therapy |
| 10/07/2009 | CN101549022A Traditional Chinese medicine preparation for treating thoracic disease |
| 10/07/2009 | CN101548995A Application of Viscum album extract as NF-kB inhibitor |
| 10/07/2009 | CN101548991A Anion plaster |
| 10/07/2009 | CN101548950A Tripterine nanometer lipid injection and method for preparing same |
| 10/07/2009 | CN101548945A Long-acting flunixin meglumine injection and method for preparing same |
| 10/07/2009 | CN101548768A Health care wine and preparation method thereof |
| 10/07/2009 | CN100547003C Antibodies to human IL-1 beta |
| 10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
| 10/07/2009 | CN100546644C Externally applied Chinese medicine lotion for treating pain caused by wind, cold and damp |
| 10/07/2009 | CN100546580C Nicotin or isonicotin benzothiazole derivatives |
| 10/07/2009 | CN100546576C Application of derivative of hesperetin as anti-inflammatory and immune medicine |
| 10/07/2009 | CN100546574C Injectable liquid formulation of paracetamol |
| 10/07/2009 | CN100546570C Effervescence tablet for wind-cold type cold |
| 10/06/2009 | US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 10/06/2009 | US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 10/06/2009 | US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 10/06/2009 | US7598272 Kinase inhibitors |
| 10/06/2009 | US7598266 Fused heterocyclic derivatives as PPAR modulators |
| 10/06/2009 | US7598258 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
| 10/06/2009 | US7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 10/06/2009 | US7598253 Reverse-turn mimetics and methods relating thereto |
| 10/06/2009 | US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 10/06/2009 | US7598240 Matrix metalloproteinase inhibitors; 4-[2-(hydroxyamino)-2-oxoethyl]-2-[3-(4-methoxyphenyl)propyl]-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxylic acid or its ethyl ester; chondrodegenerative diseases or inflammatory diseases such as arthrosis deformans |
| 10/06/2009 | US7598228 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death |
| 10/06/2009 | US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma |
| 10/06/2009 | CA2485631C System and method for transparent early detection, warning, and intervention during a medical procedure |
| 10/06/2009 | CA2301377C N-aroylphenylalanine derivatives |
| 10/01/2009 | WO2009120484A2 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 10/01/2009 | WO2009119858A1 Benzene compound, and use thereof for medical purposes |
| 10/01/2009 | WO2009119836A1 Composition for external application comprising transcription factor decoy as active ingredient |
| 10/01/2009 | WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR |
| 10/01/2009 | WO2009119601A1 Water-based adhesive skin patch comprising ketoprofen lysine salt |
| 10/01/2009 | WO2009119534A1 Novel tetrahydroisoquinoline derivative |
| 10/01/2009 | WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 10/01/2009 | WO2009118175A1 Novel p2x7r antagonists and their use |
| 10/01/2009 | WO2009117987A2 Use of boswellia acids and synthetic boswellia acid derivatives for inhibiting microsomal prostanglandin e2 synthase and cathepsin g |
| 10/01/2009 | WO2009117936A1 A pharmaceutical composition with effects of antipyretic, anti-inflammatory and analgesia and its preparation method |
| 10/01/2009 | WO2009117831A1 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties |
| 10/01/2009 | WO2009080638A3 Sulfamides as zap-70 inhibitors |
| 10/01/2009 | WO2008051306A8 Soluble tnf receptors and their use in treatment of disease |
| 10/01/2009 | US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 10/01/2009 | US20090247731 Boronic ester and acid compounds, synthesis and uses |
| 10/01/2009 | US20090247638 Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disorders |
| 10/01/2009 | US20090247634 Methods for identifying modulators of eoxin formation |
| 10/01/2009 | US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
| 10/01/2009 | US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 10/01/2009 | US20090247596 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 10/01/2009 | US20090247587 1,3-dihydroisobenzofuran derivatives |
| 10/01/2009 | US20090247558 Use of the crh (corticotropin releasing hormone) - ucn (urocortin) system in the treatment of inflammatory diseases |
| 10/01/2009 | US20090247547 Hydroxamate-based inhibitors of deacetylases b |
| 10/01/2009 | US20090247492 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
| 10/01/2009 | US20090247491 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 10/01/2009 | US20090247488 Anti-inflammatory phosphonate compounds |
| 10/01/2009 | US20090247467 Peptide epitopes of vegfr-2/kdr that inhibit angiogenesis |
| 10/01/2009 | US20090247452 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions |
| 10/01/2009 | US20090246303 Method for Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides |
| 10/01/2009 | US20090246257 Wafer formulation |
| 10/01/2009 | US20090246205 Inhibition of macrophage-stimulating protein receptor (ron) |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246147 Delivery Of Antipsychotics Through An Inhalation Route |
| 10/01/2009 | US20090246130 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules |
| 10/01/2009 | CA2719745A1 Novel p2x7r antagonists and their use |
| 10/01/2009 | CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 10/01/2009 | CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 10/01/2009 | CA2718755A1 Ketoprofen lysine salt-containing aqueous patch |
| 09/30/2009 | EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 09/30/2009 | EP2105448A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 09/30/2009 | EP2105164A1 Novel P2X7R antagonists and their use |
| 09/30/2009 | EP2105143A1 Pharmaceutical compositions based on salts of tiotropium and ciclesonide |
| 09/30/2009 | EP2105139A1 Method of producing a dry earthworm powder |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104673A2 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 09/30/2009 | EP2104535A1 Compounds and compositions as channel activating protease inhibitors |
| 09/30/2009 | EP2104534A1 New combination for use in the treatment of inflammatory disorders |
| 09/30/2009 | EP2104510A2 Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus |
| 09/30/2009 | EP2104503A1 Morpholine dopamine agonists for the treatment of pain |
| 09/30/2009 | EP2104500A2 Substituted piperizines for the treatment of pain |
| 09/30/2009 | EP2104494A1 Method for reducing inflammatory responses and inflammation |
| 09/30/2009 | EP2012811B1 Use of botulinum toxin for alleviating testicular pain |
| 09/30/2009 | EP1940844B1 Compounds and compositions as protein kinase inhibitors |
| 09/30/2009 | EP1768667B1 Cannabinoid receptor ligands |
| 09/30/2009 | EP1554290B1 Analogs and prodrugs of buprenorphine |
| 09/30/2009 | EP1549658B1 Glucose-based compounds with affinity to p-selectin |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | EP1349549B1 Novel medicament compositions based on salts of tiotropium and on ciclesonide |
| 09/30/2009 | EP1261347B1 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/30/2009 | CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof |
| 09/30/2009 | CN101543623A Green healthy bone-strengthening capsule |
| 09/30/2009 | CN101543610A Medical wine for effectively treating menalgia |
| 09/30/2009 | CN101543596A Traditional Chinese medicine composition for curing sciatica and preparation method thereof |
| 09/30/2009 | CN101543582A Chinese medicinal ointment for treating osteopathy |
| 09/30/2009 | CN101543580A Traditional Chinese medicine micro pills for treating sciatica and preparation method thereof |